Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production
Yuezhou Chen,Adam Zuiani,Stephanie Fischinger,Jyotsna Mullur,Caroline Atyeo,Meghan Travers,Felipe J N Lelis,Krista M Pullen,Hannah Martin,Pei Tong,Avneesh Gautam,Shaghayegh Habibi,Jillian Bensko,Deborah Gakpo,Jared Feldman,Blake M Hauser,Timothy M Caradonna,Yongfei Cai,John S Burke,Junrui Lin,James A Lederer,Evan Christopher Lam,Christy L Lavine,Michael S Seaman,Bing Chen,Aaron G Schmidt,Alejandro Benjamin Balazs,Douglas A Lauffenburger,Galit Alter,Duane R Wesemann,Felipe J.N. Lelis,Krista M. Pullen,Blake M. Hauser,Timothy M. Caradonna,John S. Burke,James A. Lederer,Christy L. Lavine,Michael S. Seaman,Aaron G. Schmidt,Douglas A. Lauffenburger,Duane R. Wesemann
DOI: https://doi.org/10.1016/j.cell.2020.10.051
IF: 64.5
2020-12-01
Cell
Abstract:SARS-CoV-2 antibody responses range from negligible to robust in mild COVID-19Some individuals maintain stable or increased SARS-CoV-2 IgG, while most declineThose who sustain virus-specific IgG production tend to have shorter disease coursesVirus-specific B cells from "sustainers" have more SHM early after disease resolutionAntibodies are key immune effectors that confer protection against pathogenic threats. The nature and longevity of the antibody response to SARS-CoV-2 infection is not well defined. We charted longitudinal antibody responses to SARS-CoV-2 in 92 subjects after symptomatic COVID-19. Antibody responses to SARS-CoV-2 are unimodally distributed over a broad range, with symptom severity correlating directly with virus-specific antibody magnitude. Seventy-six subjects followed longitudinally to ∼100 days demonstrated marked heterogeneity in antibody duration dynamics. Virus-specific IgG decayed substantially in most individuals, whereas a distinct subset had stable or increasing antibody levels in the same timeframe despite similar initial antibody magnitudes. These individuals with increasing responses recovered rapidly from symptomatic COVID-19 disease, harbored increased somatic mutations in virus-specific memory B cell antibody genes, and had persistent higher frequencies of previously activated CD4<sup>+</sup> T cells. These findings illuminate an efficient immune phenotype that connects rapid symptom clearance to differential antibody durability dynamics.
cell biology,biochemistry & molecular biology